Notice of Clarification to PA-12-038 "Research to Advance Vaccine Safety (R21)"
Release Date: February 27, 2013
National Institute of Allergy and Infectious Diseases (NIAID)
The National Institute of Allergy and Infectious Diseases (NIAID) will not support clinical trials under PA-12-038 "Research to Advance Vaccine Safety (R21)" consistent with NIAID’s previously announced policy regarding Investigator-Initiated Clinical Trials (http://grants.nih.gov/grants/guide/notice-files/NOT-AI-05-021.html).
All other aspects of the FOA remain unchanged.
Please direct all inquiries to:
Barbara Mulach, Ph.D.
Division of Microbiology and Infectious Diseases
National Institute of Allergy and Infectious Diseases
Room 4103, MSC-6603
6610 Rockledge Drive
Bethesda, MD 20892-6603
Telephone: (301) 496-1884
Email: bmulach@niaid.nih.gov
Weekly TOC for this Announcement
NIH Funding Opportunities and Notices
|
Office of Extramural Research (OER) |
|
National Institutes of Health (NIH) 9000 Rockville Pike Bethesda, Maryland 20892 |
|
Department of Health and Human Services (HHS) |
|
||||
|
NIH . . . Turning Discovery Into Health
Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files. |
||||||||||